Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
J Hematol Oncol. 2021 May 1;14(1):73. doi: 10.1186/s13045-021-01083-5.
J Hematol Oncol. 2021.
PMID: 33933160
Free PMC article.
Review.